サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：不眠症治療薬の世界市場規模調査＆予測、製品別（医薬品、デバイス）、販売チャネル別（処方箋、店頭販売（OTC））、地域別分析、2022-2029年
市場調査レポート
商品コード
1251590

不眠症治療薬の世界市場規模調査＆予測、製品別（医薬品、デバイス）、販売チャネル別（処方箋、店頭販売（OTC））、地域別分析、2022-2029年

Global Insomnia Therapeutics Market Size study & Forecast, by Product (Drugs, Device) by Sales Channel (Prescription, Over-the-Counter (OTC))and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
不眠症治療薬の世界市場規模調査＆予測、製品別（医薬品、デバイス）、販売チャネル別（処方箋、店頭販売（OTC））、地域別分析、2022-2029年
出版日: 2023年03月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の不眠症治療薬市場は、2021年に約28億米ドルと評価され、予測期間2022-2029年には5.3％以上の堅調な成長率で成長すると予測されています。

不眠症治療薬は、不眠症を予防するのに有効な治療法です。不眠症は、入眠や睡眠維持に困難が生じる睡眠障害です。最近では非常に一般的な疾患であり、多くの人々に影響を及ぼしています。ストレス、睡眠不足、悪い睡眠習慣、不安など、この障害にはいくつかの理由があります。また、精神的な健康、仕事のパフォーマンス、個人の生活の質にも影響を及ぼします。さらに、個人間のストレスの増加や不眠症市場へのCOVID-19の好影響が、不眠症治療薬市場を牽引しています。

いくつかの理由による世界人口のストレスレベルの増加は、不眠症につながり、不眠症治療薬の市場をさらに牽引しています。例えば、2022年には、回答者の50％が前年よりもストレスを感じていると回答しています。2019年には、この割合はわずか38%でした。ストレスの原因は、仕事量、家族の問題、個人の健康管理、個人のメンタルヘルスの問題などです。すべての年齢層が、異なる理由によってこの睡眠障害の影響を受けていました。パンデミックCOVID-19は、不眠症市場に好影響を与えました。人々は失業や予期せぬ事態のためにストレスに苦しみました。このような致命的なライフイベントは、市場における不眠症治療薬の需要を急増させました。回答者の約67％が、2020年の世界のパンデミック時に、より高いレベルのストレスを経験したと回答しています。さらに、個人の多忙なスケジュールの絶え間ない増加、より良い不眠症治療薬法の継続的な進歩や配合が需要を押し上げました。しかし、不眠症治療薬のコストが高いため、2022-2029年の予測期間を通じて市場の成長が阻害されます。

不眠症治療薬の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカです。不眠症治療薬の市場は、北米が54％のシェアを占め、圧倒的な存在感を示しています。老年人口が増加し、不眠症の有病率が高いことが不眠症治療薬市場を牽引しています。主要な市場関係者の研究開発への投資の増加や、頻繁な製品の発売によるイノベーションが、市場の需要に大きな役割を果たしています。アジア太平洋地域は、ストレスや仕事の忙しさが睡眠に影響を及ぼし、不眠症の原因となっていることから、最も成長率の高い地域と予想されます。睡眠障害の治療に対する意識の高まりが、市場需要を押し上げています。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界およびセグメント別市場の推定・予測、2019年～2029年
    • 不眠症治療薬市場、地域別、2019-2029年
    • 不眠症治療薬市場、製品別、2019-2029年
    • 不眠症治療薬市場、販売チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の不眠症治療薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 世界の不眠症治療薬市場力学

  • 不眠症治療薬市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • ストレスの発生率の増加
      • COVID-19のポジティブインパクト
    • 市場の課題
      • 不眠症治療薬の高コスト
    • 市場機会
      • 製剤の進歩
      • 多忙な仕事のスケジュールの増加

第4章 世界の不眠症治療薬市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの提言と結論
  • 主な投資機会
  • 主要成功戦略

第5章 リスク評価: COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 不眠症治療薬の世界市場：製品別

  • マーケットスナップショット
  • 不眠症治療薬の世界市場：製品別、性能別- ポテンシャル分析
  • 世界の不眠症治療薬市場：製品別推定・予測2019-2029
  • 不眠症治療薬市場、サブセグメント分析
    • 薬物
    • デバイス

第7章 不眠症治療薬の世界市場：販売チャネル別

  • マーケットスナップショット
  • 不眠症治療薬の世界市場：販売チャネル別、業績-潜在能力分析
  • 不眠症治療薬の世界市場：推定・予測（販売チャネル別） 2019-2029
  • 不眠症治療薬市場、サブセグメント分析
    • 処方箋
    • オーバー・ザ・カウンター（OTC）

第8章 不眠症治療薬の世界市場：地域別分析

  • 不眠症治療薬市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
      • 販売チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州不眠症治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋不眠症治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの不眠症治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Takeda Pharmaceutical Company Ltd.;
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Idorsia Pharmaceuticals Ltd
    • Eisai Co., Ltd.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi S.A.
    • Electromedical Products International, Inc.
    • Paratek Pharmaceuticals, Inc.
    • Sumitomo Pharma Co., Ltd.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Insomnia Therapeutics Market, report scope
  • TABLE 2. Global Insomnia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Insomnia Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Insomnia Therapeutics Market estimates & forecasts by Sales Channel 2019-2029 (USD Billion)
  • TABLE 5. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPACInsomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Insomnia Therapeutics Market, research methodology
  • FIG 2. Global Insomnia Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Insomnia Therapeutics Market, key trends 2021
  • FIG 5. Global Insomnia Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Insomnia Therapeutics Market, porters 5 force model
  • FIG 7. Global Insomnia Therapeutics Market, pest analysis
  • FIG 8. Global Insomnia Therapeutics Market, value chain analysis
  • FIG 9. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Insomnia Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 16. Europe Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 18. Latin America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 19. Global Insomnia Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Insomnia Therapeutics Market is valued at approximately USD 2.8 billion in 2021and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2022-2029.Insomnia Therapeutics is the treatment effective in preventing Insomnia. It is a sleep disorder that creates difficulty for the individual to fall or stay asleep. It is a very common disease prevailing these days and affecting a number of populations. There are several reasons for this disorder such as stress, poor sleep schedules, bad sleeping habits, anxiety and so on. It also affects mental health, work performance and quality of individual life. Additionally, increasing incidences of stress among individuals and the positive impact of COVID-19 on the insomnia market are driving the market for Insomnia Therapeutics.

The increasing stress levels among the global population due to several reasons lead to insomnia further driving the market for Insomnia Therapeutics. For instance, in 2022 50% of respondents were feeling more stressed than in the previousyear. In 2019 the percentage was just 38%. The stress can be due to workload, family issues, personal health care, and individual mental health. All age groups were affected due to this sleep disorder due to different reasons. The pandemic COVID-19 laid a positive impact on the Insomnia market. People suffered from stress due to job losses and unexpected situations. Such a deadly life event surged the demand for insomnia therapeutics in the market. Around 67% of respondents experienced higher levelsof stress during the pandemic globally in 2020. Moreover, the constant rise in hectic schedules of individuals, and continuous advancements and formulations in better insomnia treatment methods boosted the demand. However, the high cost of Insomnia Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Insomnia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for Insomnia therapeutics with a share of 54%. The growing geriatricc population and high prevalence of insomnia in this population is driving the market for Insomnia Therapeutics. The growing investments of key market players in R&D and innovations through frequent product launches play a major role in market demand. Asia-Pacific is expected to be the fastest-growing region due to increased stress and work schedules affecting sleep among the population is leading to insomnia disorders. The rising awareness to cure for sleep disorders is boosting the market demand.

Major market players included in this report are:

  • Takeda Pharmaceutical Company Ltd.;
  • Idorsia Pharmaceuticals Ltd
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Electromedical Products International, Inc.
  • Paratek Pharmaceuticals, Inc.
  • Sumitomo Pharma Co., Ltd.

Recent Developments in the Market:

  • In May 2022, QUVIVIQ a medication to treat adult patients with insomnia launched by Idorsia Ltd received approval from European Commission. The symptoms should be for at least 3 months and impact daytime working.
  • In June 2021, DAYVIGO was launched by Eisai Co., Ltd., a global leader in life science products. This launch was to treat insomnia in adults. It was also approved by U.S. Food and Drug Administration (FDA).

Global Insomnia Therapeutics Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, Sales Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByProduct:

  • Drugs
  • Device

By Sales Channel:

  • Prescription
  • Over-the-Counter (OTC)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Insomnia Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Insomnia Therapeutics Market, by Product,2019-2029 (USD Billion)
    • 1.2.3. Insomnia Therapeutics Market, by Sales Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Insomnia Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Insomnia Therapeutics Market Dynamics

  • 3.1. Insomnia Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Stress.
      • 3.1.1.2. Positive Impact of COVID-19.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Insomnia Therapeutics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation.
      • 3.1.3.2. Rising hectic work schedule.

Chapter 4. Global Insomnia Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Insomnia Therapeutics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Insomnia Therapeutics Market by Product, Performance - Potential Analysis
  • 6.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Device

Chapter 7. Global Insomnia Therapeutics Market, by Sales Channel

  • 7.1. Market Snapshot
  • 7.2. Global Insomnia Therapeutics Market by Sales Channel, Performance - Potential Analysis
  • 7.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Sales Channel 2019-2029 (USD Billion)
  • 7.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Prescription
    • 7.4.2. Over-the-Counter (OTC)

Chapter 8. Global Insomnia Therapeutics Market, Regional Analysis

  • 8.1. Insomnia Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Insomnia Therapeutics Market
    • 8.2.1. U.S.Insomnia Therapeutics Market
      • 8.2.1.1. Productbreakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Sales Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. CanadaInsomnia Therapeutics Market
  • 8.3. Europe Insomnia Therapeutics Market Snapshot
    • 8.3.1. U.K. Insomnia Therapeutics Market
    • 8.3.2. Germany Insomnia Therapeutics Market
    • 8.3.3. France Insomnia Therapeutics Market
    • 8.3.4. Spain Insomnia Therapeutics Market
    • 8.3.5. Italy Insomnia Therapeutics Market
    • 8.3.6. Rest of EuropeInsomnia Therapeutics Market
  • 8.4. Asia-PacificInsomnia Therapeutics Market Snapshot
    • 8.4.1. China Insomnia Therapeutics Market
    • 8.4.2. India Insomnia Therapeutics Market
    • 8.4.3. JapanInsomnia Therapeutics Market
    • 8.4.4. Australia Insomnia Therapeutics Market
    • 8.4.5. South Korea Insomnia Therapeutics Market
    • 8.4.6. Rest of Asia PacificInsomnia Therapeutics Market
  • 8.5. Latin America Insomnia Therapeutics Market Snapshot
    • 8.5.1. Brazil Insomnia Therapeutics Market
    • 8.5.2. MexicoInsomnia Therapeutics Market
  • 8.6. Rest of The World Insomnia Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Takeda Pharmaceutical Company Ltd.;
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. ProductSummary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Idorsia Pharmaceuticals Ltd
    • 9.2.3. Eisai Co., Ltd.
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Teva Pharmaceutical Industries Ltd.
    • 9.2.7. Sanofi S.A.
    • 9.2.8. Electromedical Products International, Inc.
    • 9.2.9. Paratek Pharmaceuticals, Inc.
    • 9.2.10. Sumitomo Pharma Co., Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption